Regnase-1 regulates Inflammation-driven pancreatic cancer development and progression

被引:0
|
作者
Okabe, Junya [1 ]
Kodama, Takahiro [2 ]
Yoshioka, Teppei [1 ]
Hikita, Hayato [3 ]
Sakamori, Ryotaro [3 ]
Tatsumi, Tomohide [3 ]
Takehara, Tetsuo [2 ]
机构
[1] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Japan
[2] Osaka Univ, Gastroenterol & Hepatol, Suita, Japan
[3] Osaka Univ, Dept Gastroenterol & Hepatol, Suita, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3205
引用
收藏
页码:1933 / 1933
页数:1
相关论文
共 50 条
  • [21] Regnase-1 and Roquin Nonredundantly Regulate Th1 Differentiation Causing Cardiac Inflammation and Fibrosis
    Cui, Xiaotong
    Mino, Takashi
    Yoshinaga, Masanori
    Nakatsuka, Yoshinari
    Hia, Fabian
    Yamasoba, Daichi
    Tsujimura, Tohru
    Tomonaga, Keizo
    Suzuki, Yutaka
    Uehata, Takuya
    Takeuchi, Osamu
    JOURNAL OF IMMUNOLOGY, 2017, 199 (12): : 4066 - 4077
  • [22] Post-transcriptional gene regulator Regnase-1 contributes to intrahepatic cholangiocarcinoma development
    Sato, Yu
    Kodama, Takahiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    CANCER SCIENCE, 2024, 115 : 1913 - 1913
  • [23] RETRACTION: GATA4 regulates inflammation-driven pancreatic ductal adenocarcinoma progression (Retraction of Vol 9, 10.3389/FCELL.2021.640391, 2021)
    Jiang, W.
    Chen, C.
    Huang, L.
    Shen, J.
    Yang, L.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [24] Sildenafil suppresses inflammation-driven colorectal cancer in mice
    Islam, Bianca N.
    Sharman, Sarah K.
    Hou, Yali
    Bridges, Allison
    Kolhe, Ravindra
    Trillo-Tinoco, JImena
    Singh, Nagendra
    Kim, Sangmi
    Sridhar, Subbaramiah
    Berger, Frankin G.
    Browning, Darren D.
    CANCER RESEARCH, 2017, 77
  • [25] Targeting Inflammation-Driven Cancer Microenvironment of Aggressive Breast Cancer
    Ueno, Naoto T.
    Semba, Takashi
    Wang, Xiaoping
    CANCER SCIENCE, 2022, 113 : 1307 - 1307
  • [26] p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
    Paul Miller
    Elliot H. Akama-Garren
    Richard P. Owen
    Constantinos Demetriou
    Thomas M. Carroll
    Elizabeth Slee
    Khatoun Al Moussawi
    Michael Ellis
    Robert Goldin
    Eric O’Neill
    Xin Lu
    Cell Death & Differentiation, 2023, 30 : 1619 - 1635
  • [27] p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
    Miller, Paul
    Akama-Garren, Elliot H.
    Owen, Richard P.
    Demetriou, Constantinos
    Carroll, Thomas M.
    Slee, Elizabeth
    Al Moussawi, Khatoun
    Ellis, Michael
    Goldin, Robert
    O'Neill, Eric
    Lu, Xin
    CELL DEATH AND DIFFERENTIATION, 2023, 30 (07): : 1619 - 1635
  • [28] Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice
    Islam, Bianca N.
    Sharman, Sarah K.
    Hou, Yali
    Bridges, Allison E.
    Singh, Nagendra
    Kim, Sangmi
    Kolhe, Ravindra
    Trillo-Tinoco, Jimena
    Rodriguez, Paulo C.
    Berger, Franklin G.
    Sridhar, Subbaramiah
    Browning, Darren D.
    CANCER PREVENTION RESEARCH, 2017, 10 (07) : 377 - 388
  • [29] Epigenetic and molecular drivers of inflammation-driven colorectal cancer
    Gordon, Marilyn
    Salla, Mohamed
    Said, Ahmed
    Natalia, Volodko
    Dieleman, Levinus
    Baksh, Shariaz
    CANCER RESEARCH, 2017, 77
  • [30] A novel terminal uridyltransferase regulates TLR4-driven IL-6 production via modulation of Regnase-1 mRNA stability
    Lin, Chia-Ching
    Shen, Yi-Ru
    Chang, Chi-Chih
    Hsu, Li-Chung
    CYTOKINE, 2017, 100 : 141 - 141